Eupraxia Pharmaceuticals Inc.
- Last sale
- Nov 12, 2026 · -2.61%
- Market cap
- $472.11M
- 60.29M shares
- Filings
- 132
FY 2025
FY 2025N/M FY25 yoy
—
—
——
—
—FY 2025N/M FY25 yoy
FY 2025+143.4% FY25 yoy
- $472.11M
- —
- —
- 5.8×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | reported | |
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported |
Pharmaceutical preparations
Eupraxia Pharmaceuticals Inc. is the 191st largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
STTKShattuck Labs, Inc.$1.0M82.5%4,880.9%$488.3MMNPRMonopar Therapeutics$0.0——$485.8MOVIDOvid Therapeutics Inc.$7.3M1,181.3%240.1%$479.4MBLSMBlossomHill Therapeutics, Inc.———$476.5MEOLSEvolus, Inc.$297.2M11.6%17.4%$475.2M
EPRXEupraxia Pharmaceuticals Inc. (this company)$0.0——$472.1M
SVASinovac Biotech Ltd$386.0M6.8%51.5%$464.9MHELPHelus Pharma Inc.———$458.0MKMDAKamada Ltd$180.5M12.1%11.2%$452.8MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Eupraxia Pharmaceuticals Inc. · CIK 1581178 · Engraved from SEC EDGAR